Ron Receptor Tyrosine Kinase Activation Confers Resistance to Tamoxifen in Breast Cancer Cell Lines
Open Access
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Enhanced Resistance to Tamoxifen by the c-ABL Proto-oncogene in Breast CancerNeoplasia, 2010
- Tamoxifen-Induced Rapid Death of MCF-7 Breast Cancer Cells Is Mediated via Extracellularly Signal-Regulated Kinase Signaling and Can Be Abrogated by EstrogenEndocrinology, 2007
- The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humansProceedings of the National Academy of Sciences, 2007
- Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway Improves Response of Long-term Estrogen-Deprived Breast Cancer Xenografts to AntiestrogensClinical Cancer Research, 2007
- Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent HER-Targeted TherapyJNCI: Journal of the National Cancer Institute, 2007
- Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells with Aberrant Akt ActivityClinical Cancer Research, 2004
- Overexpression of the RON gene in human breast carcinomaOncogene, 1998
- Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.1996
- Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein KinaseScience, 1995
- Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein.1993